| P50 | author | Elisabeth de Vries | Q64712784 |
| P2093 | author name string | A Groenewegen | |
| | I P Kema | |
| | D T Sleijfer | |
| | W T van der Graaf | |
| | C P Schröder | |
| P2860 | cites work | Progress in the control of acute and delayed emesis induced by cisplatin | Q28326545 |
| | Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications | Q36184956 |
| | 5-Hydroxytryptamine and 5-Hydroxytryptamine-3 Receptor Antagonists | Q36924140 |
| | Serotonin uptake and serotonin uptake inhibition | Q38004484 |
| | Metoclopramide. A review of antiemetic trials. | Q40236388 |
| | Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis | Q41159971 |
| | Cisplatin induced emesis: preliminary results indicative of changes in plasma levels of 5-hydroxytryptamine | Q41791586 |
| | Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and Vomiting | Q42136434 |
| | Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs | Q42371534 |
| | Prevention of chemotherapy-induced nausea and emesis in patients responding poorly to previous antiemetic therapy. Comparing tropisetron with optimised standard antiemetic therapy | Q45393736 |
| | Nausea and vomiting as major complications of cancer chemotherapy. | Q52096253 |
| | Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study. | Q53708801 |
| | Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. | Q55054035 |
| | Dose granisetron remain effective over multiple cycles? The Granisetron Study Group | Q67491837 |
| | In vitro release and tissue levels of ileal serotonin after cisplatin-induced emesis in the cat | Q67895386 |
| | Improved diagnosis of carcinoid tumors by measurement of platelet serotonin | Q67896103 |
| | The 5-hydroxytryptamine system of blood platelets: physiology and pathophysiology | Q69751849 |
| | Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting | Q70177918 |
| | A simple paired-ion liquid chromatography assay for serotonin in cerebrospinal fluid, platelet-rich plasma, serum and urine | Q70700074 |
| | Urinary serotonin metabolite excretion during cisplatin chemotherapy | Q72095534 |
| | Liquid-chromatographic determination of urinary 5-hydroxy-3-indoleacetic acid, with fluorescence detection | Q72656288 |
| P433 | issue | 6 | |
| P921 | main subject | platinum | Q880 |
| | chemotherapy | Q974135 |
| P304 | page(s) | 477-482 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
| P1476 | title | Serotonin metabolism following platinum-based chemotherapy combined with the serotonin type-3 antagonist tropisetron | |
| P478 | volume | 36 | |